[go: up one dir, main page]

IL158056A0 - Chemical derivatives and their use as anti-telomerase agent - Google Patents

Chemical derivatives and their use as anti-telomerase agent

Info

Publication number
IL158056A0
IL158056A0 IL15805602A IL15805602A IL158056A0 IL 158056 A0 IL158056 A0 IL 158056A0 IL 15805602 A IL15805602 A IL 15805602A IL 15805602 A IL15805602 A IL 15805602A IL 158056 A0 IL158056 A0 IL 158056A0
Authority
IL
Israel
Prior art keywords
chemical derivatives
telomerase agent
telomerase
agent
derivatives
Prior art date
Application number
IL15805602A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0103916A external-priority patent/FR2822468B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL158056A0 publication Critical patent/IL158056A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15805602A 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent IL158056A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0103916A FR2822468B1 (fr) 2001-03-23 2001-03-23 Derives chimiques et leur application comme agent anti-telomerase
FR0110370 2001-08-02
PCT/FR2002/001005 WO2002076975A1 (fr) 2001-03-23 2002-03-22 Derives chimiques et leur application comme agent antitelomerase

Publications (1)

Publication Number Publication Date
IL158056A0 true IL158056A0 (en) 2004-03-28

Family

ID=26212933

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15805602A IL158056A0 (en) 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent
IL158056A IL158056A (en) 2001-03-23 2003-09-22 Chemical derivatives and pharmaceutical compositions containing them for use as anti-telomerase agent

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158056A IL158056A (en) 2001-03-23 2003-09-22 Chemical derivatives and pharmaceutical compositions containing them for use as anti-telomerase agent

Country Status (11)

Country Link
EP (1) EP1373252A1 (es)
JP (1) JP2004524349A (es)
AR (1) AR034297A1 (es)
AU (1) AU2002251140B2 (es)
CA (1) CA2442012A1 (es)
CO (1) CO5380035A1 (es)
IL (2) IL158056A0 (es)
MX (1) MXPA03008269A (es)
MY (1) MY130957A (es)
PE (1) PE20020959A1 (es)
WO (1) WO2002076975A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002314252A1 (en) * 2001-05-28 2002-12-09 Aventis Pharma S.A. Chemical derivatives and the use thereof as an anti-telomerase agent
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
AU2002361846A1 (en) * 2001-12-21 2003-07-15 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
AU2003253735A1 (en) * 2002-06-25 2004-01-06 The Center For Blood Research, Inc. Vacuolins
FR2850970B1 (fr) * 2003-02-07 2006-07-07 Aventis Pharma Sa Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique
KR101218213B1 (ko) 2003-07-03 2013-01-04 시토비아 인크. 카스파제의 활성인자 및 세포자멸사의 유도인자로서의4-아릴아미노-퀴나졸린
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
EP1833482A4 (en) 2005-01-03 2011-02-16 Myriad Genetics Inc COMPOUNDS AND ITS THERAPEUTIC USE
ZA200709959B (en) * 2005-05-19 2009-04-29 Prometic Biosciences Inc Triazine compounds and compositions thereof for the treatment of cancers
EP2441757A1 (en) * 2006-07-31 2012-04-18 Praecis Pharmaceuticals Incorporated Aurora kinase inhibitors from an encoded small molecule library
ES2392003T3 (es) * 2007-07-25 2012-12-03 Bristol-Myers Squibb Company Inhibidores de la triazina quinasa
FR2948686B1 (fr) * 2009-07-30 2011-08-19 Biomerieux Sa Nouveaux substrats de peptidase
WO2019181714A1 (ja) * 2018-03-20 2019-09-26 国立大学法人広島大学 テロメア結合タンパク質を阻害する化合物、及びそれを含むテロメア結合タンパク質阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206768D0 (en) * 1992-03-27 1992-05-13 Jarman Michael New compounds for use in the treatment of cancer
JPH1160573A (ja) * 1997-08-22 1999-03-02 Nippon Kayaku Co Ltd トリアジン誘導体及びテロメラーゼ阻害剤
US6262053B1 (en) * 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
EE200200263A (et) * 1999-11-29 2003-06-16 Aventis Pharma S.A. Telomeeride G-kvadrupleksstruktuuri fikseerivad ühendid, nende kasutamine ja terapeutilised kombinatsioonid
MXPA04007590A (es) * 2002-02-05 2004-12-06 Yamanouchi Pharma Co Ltd Derivado de 2,4,6-triamino-1,3,5-triacina.

Also Published As

Publication number Publication date
MY130957A (en) 2007-07-31
IL158056A (en) 2010-02-17
AU2002251140B2 (en) 2007-03-15
EP1373252A1 (fr) 2004-01-02
CA2442012A1 (fr) 2002-10-03
CO5380035A1 (es) 2004-03-31
JP2004524349A (ja) 2004-08-12
AR034297A1 (es) 2004-02-18
WO2002076975A1 (fr) 2002-10-03
PE20020959A1 (es) 2002-12-17
MXPA03008269A (es) 2004-10-15

Similar Documents

Publication Publication Date Title
IL162266A (en) Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the use of the same
AUPR879601A0 (en) Novel chemical compounds and their use
MXPA03006260A (es) Derivados de amina sustituidos y metodos de uso.
ZA200300545B (en) Novel heteroaryl derivatives and use thereof as anti-tumour agents.
IL150701A0 (en) 4-aminopicolinates and their use as herbicides
HUP0401335A3 (en) Herbicidal pyridylpropynyloxyphenyl derivatives, preparation and use thereof
AU8729901A (en) Benzoylpyrazols and their use as herbicides
AU2002358700A8 (en) Urea derivatives as vr1- antagonists
AU2002314252A1 (en) Chemical derivatives and the use thereof as an anti-telomerase agent
HUP0402025A3 (en) Novel bensophenone derivatives or salts thereof and their use
HUP0401756A3 (en) Substituted benzimidazole compounds and their use
IL158056A0 (en) Chemical derivatives and their use as anti-telomerase agent
AU2002251140A1 (en) Chemical derivatives and their use as anti-telomerase agent
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
GB0126889D0 (en) Compounds and their uses
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
AUPR879701A0 (en) Novel chemical compounds and their use
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
HUP0401162A3 (en) Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
IL156794A0 (en) Chemical derivatives and their use as anti-telomerase agent
AU2002229859A1 (en) Chemical derivatives and their use as anti-telomerase agent
AU2001282268A1 (en) Phenantridine derivatives and their use as anti-telomerase agent
EP1367123A4 (en) NEUROTONIN AND ITS USE
GB0106987D0 (en) Immunotherapeuitic agent
GB0122162D0 (en) Agent